A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
Curigliano, Giuseppe, Romieu, Gilles, Campone, Mario, Dorval, Thierry, Duck, Lionel, Canon, Jean-Luc, Roemer-Becuwe, Celia, Roselli, Mario, Neciosup, Silvia, Burny, Wivine, Callegaro, Andrea, de SousaVolume:
156
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-016-3750-y
Date:
April, 2016
File:
PDF, 784 KB
2016